BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 15452908)

  • 21. Malignant breast lesions that may mimic benign tumors.
    Weidner N
    Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade.
    Allison KH; Eby PR; Kohr J; DeMartini WB; Lehman CD
    Hum Pathol; 2011 Jan; 42(1):41-50. PubMed ID: 20970167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Breast lesion diagnosis: integrating pathology and radiology].
    Zonderland HM; van de Vijver MJ; Visser M
    Ned Tijdschr Geneeskd; 2011; 155(18):A2967. PubMed ID: 21466724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of papillary lesions at percutaneous breast biopsy.
    Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
    Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
    Kurniawan ED; Rose A; Mou A; Buchanan M; Collins JP; Wong MH; Miller JA; Mann GB
    Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management.
    Gresik CM; Godellas C; Aranha GV; Rajan P; Shoup M
    Surgery; 2010 Oct; 148(4):752-7; discussion 757-8. PubMed ID: 20708765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In situ ductal carcinoma of the breast: a diagnostic challenge].
    Fuchsjäger MH; Helbich TH
    Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine-needle aspiration of the breast: diagnostic problems and approaches to surgical management.
    Sneige N; Singletary SE
    Pathol Annu; 1994; 29 Pt 1():281-301. PubMed ID: 8127626
    [No Abstract]   [Full Text] [Related]  

  • 32. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary lesions of the breast: selected diagnostic and management issues.
    Collins LC; Schnitt SJ
    Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fiberoptic ductoscopy-guided intraductal biopsy improve the diagnosis of nipple discharge.
    Ling H; Liu GY; Lu JS; Love S; Zhang JX; Xu XL; Xu WP; Shen KW; Shen ZZ; Shao ZM
    Breast J; 2009; 15(2):168-75. PubMed ID: 19292803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillary lesions of the breast.
    Ibarra JA
    Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
    Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
    Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.